Huashan Hospital

This study tests a 6-month, all-oral drug combination (BDLLfxC) for people with rifampin-resistant tuberculosis. About 120 teenagers and adults in China will take the pills and be followed for up to 72 weeks. The goal is to see if this shorter treatment can cure the infection saf…

This study was designed to test a new treatment called GC012F, a type of CAR T cell therapy, in people with multiple sclerosis. The goal was to see if it is safe and if it can help control the disease. However, the study was withdrawn before any participants were enrolled, so no …

This study aims to collect health and genetic information from 500 Chinese adults with myotonic dystrophy type 1 (DM1), a muscle-weakening disease. Researchers will measure walking speed and daytime sleepiness to see how the condition affects daily life. The goal is to learn more…

This study follows 1,800 adults with chronic kidney disease (not on dialysis) to see how nutrition and lifestyle affect their health over time. Researchers will track heart health, bone health, thinking skills, and daily function using hospital records and a mobile app. The goal …